Heart surgery patients given carb drink show better insulin response
NCT ID NCT07212153
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether drinking a carbohydrate beverage two hours before cardiac surgery could lower insulin resistance, a condition that can raise blood sugar and slow recovery. Fifty adults undergoing heart surgery were randomly assigned to receive either a maltodextrin drink or plain water. Researchers measured insulin and glucose levels before and after surgery to compare the effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Maltodextrin (carbohydrate drink)
What this could lead to
If it works, this could lead to a simple, low-cost way to reduce insulin resistance and speed recovery after heart surgery.
What could go wrong
This is a small, completed trial with only 50 participants. Results may not apply to people with diabetes or other conditions, and the benefit may be small.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RSUP Dr. Sardjito
Sleman, D.I.Yogyakarta, 55281, Indonesia